Yasuo Watanabe Selected Research

Chronic Subdural Hematoma

1/2021	Sequential Expression of Chemokines in Chronic Subdural Hematoma Fluids after Trepanation Surgery.
1/2020	Expression of high mobility group B1 and toll-like receptor-nuclear factor κB signaling pathway in chronic subdural hematomas.
11/2017	Expression of Caspase Signaling Components in the Outer Membranes of Chronic Subdural Hematomas.
1/2017	Inhibitory Mechanism of the Outer Membrane Growth of Chronic Subdural Hematomas.
1/2017	Activation of Nuclear Factor-kappa B in Endothelial Cells of Chronic Subdural Hematoma Outer Membranes.
7/2016	Activation of Signal Transducer and Activator of Transcription 3 in Endothelial Cells of Chronic Subdural Hematoma Outer Membranes.
7/2015	Expression of Mitogen-Activated Protein Kinases in Chronic Subdural Hematoma Outer Membranes.
8/2014	Eotaxin-3 activates the Smad pathway through the transforming growth factor beta 1 in chronic subdural hematoma outer membranes.
12/2012	Activation of Ras/MEK/ERK signaling in chronic subdural hematoma outer membranes.
6/2011	Activation of PI3 kinase/Akt signaling in chronic subdural hematoma outer membranes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuo Watanabe Research Topics

Disease

12	Neoplasms (Cancer) 04/2016 - 01/2002
10	Chronic Subdural Hematoma 01/2021 - 06/2011
10	Brain Ischemia (Cerebral Ischemia) 12/2018 - 12/2002
9	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 02/2006
7	Ischemia 12/2018 - 09/2002
6	Brain Diseases (Brain Disorder) 01/2021 - 12/2002
5	Human Influenza (Influenza) 06/2008 - 12/2002
4	Infections 01/2022 - 06/2003
4	Inflammation (Inflammations) 01/2021 - 01/2017
4	Carcinoma (Carcinomatosis) 01/2017 - 08/2002
3	Acidosis 08/2007 - 01/2002
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2005 - 12/2002
3	Meningitis 08/2004 - 06/2002
3	Squamous Cell Carcinoma of Head and Neck 07/2002 - 01/2002
2	Ischemic Stroke 07/2018 - 11/2004
2	Parkinson Disease (Parkinson's Disease) 01/2018 - 11/2005
2	Dehydration (Water Stress) 01/2017 - 12/2016
2	Breast Neoplasms (Breast Cancer) 04/2016 - 05/2004
2	Hyperglycemia 04/2016 - 12/2004
2	Brain Injuries (Brain Injury) 08/2015 - 11/2008
2	Intracranial Vasospasm 08/2014 - 04/2012
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2014 - 06/2007
2	Thrombosis (Thrombus) 10/2012 - 05/2007
2	Ovarian Epithelial Carcinoma 04/2006 - 08/2002
2	Encephalitis (Encephalitis, Rasmussen) 08/2004 - 04/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2003 - 07/2002
2	Lymphatic Metastasis 07/2002 - 01/2002
1	Pneumothorax 07/2021
1	Dementia (Dementias) 01/2021
1	Cognitive Dysfunction 12/2018
1	Exanthema (Rash) 04/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2016

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
8	CytokinesIBA 01/2017 - 02/2006
7	Neuroprotective AgentsIBA 07/2018 - 12/2002
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2018 - 08/2004
5	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2020 - 09/2002
4	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2018 - 09/2002
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2012 - 06/2007
4	NitratesIBA 06/2007 - 12/2002
4	NitritesIBA 06/2007 - 12/2002
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2018 - 12/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2008
3	EnzymesIBA 01/2017 - 01/2008
3	Calcium-Calmodulin-Dependent Protein KinasesIBA 10/2013 - 11/2008
3	Messenger RNA (mRNA)IBA 04/2013 - 05/2006
3	SurvivinIBA 04/2006 - 07/2002
3	alloseIBA 10/2005 - 01/2003
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2008
2	ChemokinesIBA 01/2021 - 01/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2018 - 01/2018
2	Indicators and Reagents (Reagents)IBA 08/2015 - 01/2005
2	Phosphates (Orthophosphate)IBA 01/2015 - 11/2014
2	CalciumIBA 11/2014 - 11/2011
2	Immunoglobulin G (IgG)IBA 05/2014 - 01/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2012 - 05/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012 - 11/2004
2	SaltsIBA 05/2012 - 01/2003
2	InterleukinsIBA 12/2011 - 01/2008
2	Free RadicalsIBA 12/2011 - 01/2008
2	Peptides (Polypeptides)IBA 09/2008 - 03/2005
2	Pharmaceutical PreparationsIBA 01/2008 - 06/2003
2	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 04/2006 - 03/2003
2	SugarsIBA 11/2005 - 07/2005
2	psicose (D-psicose)IBA 11/2005 - 07/2005
1	Immunoglobulin E (IgE)IBA 01/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	Chemotactic FactorsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2018
1	EdaravoneIBA 07/2018
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 01/2018
1	CaspasesIBA 11/2017
1	Janus KinasesIBA 01/2017
1	cysteinylcysteineIBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	Hydro-Lyases (Dehydratases)IBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	1,4-naphthoquinoneIBA 01/2017
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2017
1	trans-4-hydroxy-L-prolineIBA 01/2017
1	hydroxyproline epimeraseIBA 01/2017
1	Proline (L-Proline)FDA Link 12/2016
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2016
1	Insulin-Like PeptidesIBA 04/2016
1	KW-2450IBA 04/2016
1	Lapatinib (GW572016)FDA Link 04/2016
1	Letrozole (Femara)FDA LinkGeneric 04/2016
1	ErbB Receptors (EGF Receptor)IBA 04/2016
1	CateninsIBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 07/2015

Therapy/Procedure

3	Therapeutics 07/2021 - 04/2004
2	Trephining 01/2021 - 01/2017
2	Traction 05/2006 - 02/2005
1	Conservative Treatment 07/2021
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2021
1	Oral Administration 01/2016